For starters angiotensin converting enzyme inhibitors (ACEI), which are historically known for their anti-hypertensive properties, are reported to mitigate heart failure by reducing cardiac afterload and systolic wall stress, decreasing aldosterone-induced fibrosis and apoptosis, whilst improving ventricular geometry (55, 56). The gene discussed is ACE; the disease is heart failure.